Yale University

Funding Organization

Awards Grant

  • A Feasibility Trial of Esketamine Plus Cognitive Behavioral Therapy for Patients with Major Depressive Disorder Who are Hospitalized for Suicidal Ideation
  • Accelerating Inflammation Resolution to CounterACT Chemical Injury
  • Age-Dependent Heterogeneity in The Efficacy of Prophylaxis with Enoxaparin Against Catheter-Associated Thrombosis in Critically Ill Children
  • Community-Based HIV Education Research Program for Diverse Racial & Ethnic Groups :Engagement and Retention in Care: Positive Sistahs Engaged for Life
  • Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity
  • EMBED: Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder
  • EMBED: Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder
  • Embed: Pragmatic Trial Of User-Centered Clinical Decision Support To Implement Emergency Department-Initiated Buprenorphine For Opioid Use Disorder
  • Gene Targets for Intraventricular Hemorrage (IVH)
  • Human Genetics and Molecular Mechanisms of Congenital Hydrocephalus
  • Impact of Potentially Inappropriate Medications Prescribed at Emergency Department Discharge on Geriatric Patient-Level Outcomes
  • Normal Aging Lung Cell Atlas (NALCA)
  • Plasma NTx and Vitamin D Levels as Prognostic Factors for Surgical Outcomes after Midurethral Slings
  • Pregnancy in Polycystic Ovary Syndrome II (PCOSII)
  • Project Relevant Implementation Strategies to Enhance (RISE) Status Neutral Community Health Workers in Alabama and Missouri (AL-MO)
  • Research Education Institute for Diverse Scholars (REIDS)
  • Restoring GABA Inhibition in ASD by Turning a Kinase-Regulated CI-Rheostat
  • Robust Workflow Software for MRI Tracking of Glymphatic-Lymphatic Coupling
  • Targeting Injury Pathways to Counteract Pulmonary Agent and Vesicant Toxicity
  • The Autism Biomarkers Consortium for Clinical Trials (ABC-CT)
  • Understanding and Manipulating Cellular and Circuit-level Vulnerability to Neurodegeneration in Parkinson’s Disease
  • Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial (AM1) Infarction Patients --VIRGO
  • Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI)
  • Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI)